ATE439367T1 - Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen - Google Patents

Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen

Info

Publication number
ATE439367T1
ATE439367T1 AT05739739T AT05739739T ATE439367T1 AT E439367 T1 ATE439367 T1 AT E439367T1 AT 05739739 T AT05739739 T AT 05739739T AT 05739739 T AT05739739 T AT 05739739T AT E439367 T1 ATE439367 T1 AT E439367T1
Authority
AT
Austria
Prior art keywords
treatment
microbial infections
ester bonded
macrolides
macrolides suitable
Prior art date
Application number
AT05739739T
Other languages
English (en)
Inventor
Sulejman Alihodzic
Stjepan Mutak
Drazen Pavlovic
Ivana Palej
Vlado Stimac
Samra Kapic
Adrijana Vinter
Skugor Maja Matanovic
Original Assignee
Glaxosmithkline Zagreb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Zagreb filed Critical Glaxosmithkline Zagreb
Application granted granted Critical
Publication of ATE439367T1 publication Critical patent/ATE439367T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
AT05739739T 2004-05-06 2005-05-02 Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen ATE439367T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56940204P 2004-05-06 2004-05-06
US58111804P 2004-06-18 2004-06-18
PCT/IB2005/001186 WO2005108412A1 (en) 2004-05-06 2005-05-02 Ester linked macrolides useful for the treatment of microbial infections

Publications (1)

Publication Number Publication Date
ATE439367T1 true ATE439367T1 (de) 2009-08-15

Family

ID=34967616

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05739739T ATE439367T1 (de) 2004-05-06 2005-05-02 Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen

Country Status (16)

Country Link
US (1) US20080255060A1 (de)
EP (1) EP1756135B1 (de)
JP (1) JP2007536371A (de)
AR (1) AR049269A1 (de)
AT (1) ATE439367T1 (de)
AU (1) AU2005240849B2 (de)
BR (1) BRPI0510328A (de)
CA (1) CA2566085A1 (de)
DE (1) DE602005015963D1 (de)
ES (1) ES2331739T3 (de)
IL (1) IL178876A0 (de)
MA (1) MA28640B1 (de)
MX (1) MXPA06012923A (de)
NO (1) NO20065662L (de)
RU (1) RU2006143051A (de)
WO (1) WO2005108412A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3738591A3 (de) 2003-03-10 2021-03-24 Merck Sharp & Dohme Corp. Neuartige antibakterielle wirkstoffe
WO2006120541A1 (en) * 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
EP2362727B1 (de) 2008-10-24 2018-04-11 Cempra Pharmaceuticals, Inc. Verfahren zur behandlung von resistenten krankheiten mit traizolhaltigen makroliden
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN102724874B (zh) 2009-09-10 2018-06-01 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
SI2571506T1 (sl) 2010-05-20 2017-12-29 Cempra Pharmaceuticals, Inc. Postopki za pripravo makrolidov in ketolidov ter njihovih intermediatov
WO2012034058A1 (en) 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
JP6208742B2 (ja) 2012-03-27 2017-10-04 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗生物質を投与するための非経口製剤
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
CA2525455A1 (en) * 2003-05-13 2004-11-25 Glaxo Group Limited Novel 14 and 15 membered-ring compounds
WO2006120541A1 (en) * 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections

Also Published As

Publication number Publication date
WO2005108412A1 (en) 2005-11-17
EP1756135B1 (de) 2009-08-12
RU2006143051A (ru) 2008-06-20
ES2331739T3 (es) 2010-01-14
IL178876A0 (en) 2007-03-08
NO20065662L (no) 2007-01-16
MXPA06012923A (es) 2007-07-18
BRPI0510328A (pt) 2007-10-23
AU2005240849B2 (en) 2008-10-23
AR049269A1 (es) 2006-07-12
DE602005015963D1 (de) 2009-09-24
US20080255060A1 (en) 2008-10-16
JP2007536371A (ja) 2007-12-13
AU2005240849A1 (en) 2005-11-17
CA2566085A1 (en) 2005-11-17
EP1756135A1 (de) 2007-02-28
MA28640B1 (fr) 2007-06-01

Similar Documents

Publication Publication Date Title
ATE439367T1 (de) Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen
DE602005019899D1 (de) System zur behandlung von ischämischem schlaganfall
ATE478864T1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
WO2006023651A3 (en) Extended treatment of multiple sclerosis
DE602005027052D1 (de) Endoskopbehandlungssystem
ATE424386T1 (de) Pyridin-verbindungen für die behandlung von prostaglandin-vermittelten krankheiten
SMP200900085B (it) 3-imidazolil-indoli per il trattamento di malattieproliferative.
DK1765391T3 (da) Bakterielle præparater til behandlingen af cancer
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
ATE437861T1 (de) 2-(amino-substituierte)-4-arylpyramidine und verwandte verbindungen, die sich für die behandlung von entzündlichen krankheiten eignen
NL1028599A1 (nl) Verbindingen voor de behandeling van ziekten.
NL1026203A1 (nl) Verbindingen toepasbaar voor de behandeling van ziekten.
GB0513096D0 (en) Treatment of microbial infections
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE602005021084D1 (de) ENDOSKOPisches BEHANDLUNGSSYSTEM
ATE526970T1 (de) Behandlung von mastitis
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
MA28694B1 (fr) Traitement des infections bacteriennes
DK1656143T3 (da) Quinolon-antibiotika til behandling af periodontale infektioner
DE602004009733D1 (de) Dynamisches Ratenteilungsverfahren
NO20054034D0 (no) Fremgangsmate for behandling av hypotyroidisme.
AT500549B8 (de) Klärbecken
DE602005019721D1 (de) Zusammensetzungen mit mannosephosphat für die vaginale behandlung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties